Global X Genomics & Biotechnology ETF Rating $8.71 -0.01 (-0.11%) Closing price 08/7/2025 03:59 PM EasternExtended Trading$8.90 +0.19 (+2.18%) As of 08/7/2025 07:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOptions ChainOwnershipRatingsShort InterestTrendsBuy This Stock Global X Genomics & Biotechnology ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.GNOM Aggregate RatingModerate Buy 2.70Holdings in GNOM have an aggregate rating of Moderate Buy based on 385 analyst ratings issued in the past year covering 23 companies (79.3% of the portfolio).GNOM Aggregate Price Target$8.71High Prediction$8.71Average Prediction$8.71Low Prediction$8.71Holdings in GNOM have an aggregate price target of $8.71 and a range of $8.71 to $8.71 covering 23 companies (79.3% of the portfolio).GNOM Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy5 Buy rating(s)Moderate Buy14 Moderate Buy rating(s)Hold4 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Global X Genomics & Biotechnology ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 23 GNOM Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings6.42%ALNYAlnylam Pharmaceuticals$435.10+1.6%3.9046 of 5 stars2.85$403.92 -7.2%27Earnings ReportAnalyst Upgrade5.62%CRSPCRISPR Therapeutics$55.96-0.7%3.6761 of 5 stars2.50$71.60 27.9%16Trending NewsEarnings ReportAnalyst ForecastAnalyst Revision4.80%ILMNIllumina$95.50+1.1%4.8813 of 5 stars2.40$127.74 33.8%20Positive NewsEarnings ReportAnalyst ForecastAnalyst Revision4.56%QGENQIAGEN$48.32+1.7%3.5371 of 5 stars2.27$49.69 2.8%11News CoverageEarnings ReportAnalyst Forecast4.52%RNAAvidity Biosciences$47.52-1.5%2.7559 of 5 stars3.06$66.35 39.6%17News CoverageUpcoming EarningsGap Down4.37%LEGNLegend Biotech$37.43-0.6%3.8424 of 5 stars3.00$73.33 95.9%11News CoveragePositive NewsUpcoming EarningsAnalyst UpgradeAnalyst Revision4.23%TECHBio-Techne$50.15+0.6%4.8798 of 5 stars2.62$69.42 38.4%13Trending NewsEarnings ReportDividend AnnouncementAnalyst Forecast4.02%MRNAModerna$26.61-0.4%4.3279 of 5 stars2.04$43.59 63.8%24Trending NewsEarnings ReportAnalyst ForecastAnalyst Revision3.63%BMRNBioMarin Pharmaceutical$59.46-2.0%4.9934 of 5 stars2.75$93.17 56.7%24Trending NewsAnalyst ForecastAnalyst Revision3.63%VRTXVertex Pharmaceuticals$375.63-2.6%4.9167 of 5 stars2.56$497.10 32.3%27Trending NewsEarnings ReportAnalyst ForecastInsider TradeAnalyst RevisionHigh Trading Volume3.61%BNTXBioNTech$111.35+0.0%1.9708 of 5 stars2.76$135.91 22.1%17Earnings ReportAnalyst Forecast3.51%GHGuardant Health$50.39+13.0%2.9976 of 5 stars3.05$54.95 9.0%20Gap UpHigh Trading Volume3.50%NTRANatera$141.08+2.1%3.7255 of 5 stars3.06$183.76 30.3%16Trending NewsEarnings ReportInsider TradeHigh Trading Volume3.20%WGSGeneDx$105.95+0.1%3.0566 of 5 stars2.75$101.63 -4.1%8Analyst Forecast2.94%RAREUltragenyx Pharmaceutical$27.83-0.8%4.4036 of 5 stars2.92$82.17 195.2%12Trending NewsEarnings ReportAnalyst ForecastAnalyst Revision2.40%TWSTTwist Bioscience$25.00-3.5%3.5427 of 5 stars2.73$49.40 97.6%11News CoverageEarnings ReportAnalyst ForecastAnalyst Revision2.30%VCYTVeracyte$27.68+15.5%2.6902 of 5 stars2.70$40.90 47.8%10Trending NewsGap Up2.30%ARWRArrowhead Pharmaceuticals$16.06-1.5%3.8219 of 5 stars2.89$43.71 172.2%9Positive NewsEarnings ReportAnalyst RevisionGap Up2.09%AAgilent Technologies$113.88+0.6%4.568 of 5 stars2.54$139.77 22.7%13Positive News2.05%BEAMBeam Therapeutics$17.86-2.4%2.7432 of 5 stars3.07$48.45 171.3%14News CoverageEarnings ReportAnalyst ForecastAnalyst Revision2.05%GILDGilead Sciences$110.284.6518 of 5 stars2.81$112.36 1.9%26Trending NewsEarnings Report1.77%LLYEli Lilly and Company$640.17-14.2%4.8916 of 5 stars2.71$999.50 56.1%21Trending NewsEarnings ReportAnalyst ForecastGap DownHigh Trading Volume1.76%BMYBristol Myers Squibb$45.32+1.1%4.6165 of 5 stars2.24$56.38 24.4%21Earnings ReportAnalyst DowngradeAnalyst RevisionGap Down This page (NASDAQ:GNOM) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredSell this, buy thatWhat you don’t own matters just as much as what you do. That’s the thinking behind Eric Fry’s long-time strate...InvestorPlace | SponsoredAmazon’s big Bitcoin embarrassmentBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | SponsoredAltucher: Trump’s Great Gain is startingNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredCritical AI announcement set to ignite AI 2.0 A new 100% tariff on imported chips just rattled the tech sector—sending some stocks soaring and others tumbli...Timothy Sykes | SponsoredTrump’s new nightmareAccording to Porter Stansberry and Jeff Brown, a government-led financial mobilization is already reshaping Am...Porter & Company | SponsoredThe Day Silicon DiesThe Day China Left America's Supercomputers in the Dust In 200 seconds, China's quantum computer accomplish...The Oxford Club | SponsoredThis accelerated income plan is solving American's #1 retirement fearThe #1 fear in retirement today? Running out of money. That’s why income expert Tim Plaehn created a simple...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Global X Genomics & Biotechnology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Global X Genomics & Biotechnology ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GNOM Stock Alerts